Phathom Pharmaceuticals, Inc.

CITADEL ADVISORS LLC PHAT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

311,315

Value ($000)

5,165

Weight

0.0%

2020 Q1 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	5,165	0.0%	311,315	12/31/2025
2025 Q3	11/14/2025	5,988	0.0%	508,720	9/30/2025
2025 Q1	5/15/2025	1,127	0.0%	179,721	3/31/2025
2024 Q4	2/14/2025	585	0.0%	72,007	12/31/2024
2024 Q3	11/14/2024	3,985	0.0%	220,403	9/30/2024
2024 Q2	8/14/2024	812	0.0%	78,816	6/30/2024
2024 Q1	5/15/2024	1,334	0.0%	125,645	3/31/2024
2023 Q4	2/14/2024	105	0.0%	11,533	12/31/2023
2023 Q3	11/14/2023	2,859	0.0%	275,727	9/30/2023
2023 Q2	8/14/2023	242	0.0%	16,915	6/30/2023
2023 Q1	5/15/2023	1,346	0.0%	188,484	3/31/2023
2022 Q4	2/14/2023	20	0.0%	1,753	12/31/2022
2022 Q2	8/15/2022	212	0.0%	25,012	6/30/2022
2021 Q4	2/14/2022	226	0.0%	11,466	12/31/2021
2021 Q3	11/15/2021	623	0.0%	19,410	9/30/2021
2021 Q2	8/16/2021	2,721	0.0%	80,374	6/30/2021
2021 Q1	5/21/2021	321	0.0%	8,541	3/31/2021
2020 Q4	2/16/2021	401	0.0%	12,076	12/31/2020
2020 Q3	11/16/2020	246	0.0%	6,716	9/30/2020
2020 Q1	5/15/2020	308	0.0%	11,948	3/31/2020